Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
EXAGEN INC. (XGN)
|
Add to portfolio |
|
|
|
| Price: |
$11.06
| | Metrics |
| OS: |
16.9
|
M
| |
-111
|
% ROE
|
| Market cap: |
$186
|
M
| |
-114
|
% ROIC
|
|
Net cash:
|
$12.1
|
M
| |
$0.72
|
per share
|
|
EV:
|
$174
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($27.4)
|
M
| |
|
|
|
EBIT
|
($29.4)
|
M
| |
|
|
| EPS |
($2.05)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-15 |
| Revenues | 45.6 | 48.3 | 42.0 | 40.4 | 32.4 | 32.4 | 26.8 | 17.9 |
| Revenue growth | -5.7% | 15.1% | 3.9% | 24.5% | 21.0% | | | 53.9% |
| Cost of goods sold | 24.2 | 20.6 | 16.6 | 18.8 | 15.4 | 15.4 | 14.1 | 9.5 |
| Gross profit | 21.3 | 27.7 | 25.4 | 21.6 | 17.1 | 17.1 | 12.7 | 8.4 |
| Gross margin | 46.9% | 57.4% | 60.6% | 53.4% | 52.6% | 52.6% | 47.3% | 46.9% |
| Selling, general and administrative | 52.0 | 44.5 | 37.0 | 28.7 | 19.7 | 19.7 | 18.8 | 17.4 |
| Research and development | 9.9 | 7.2 | 3.6 | 2.2 | 2.1 | 2.1 | 1.6 | 1.4 |
| EBITA | -40.5 | -24.1 | -15.2 | -9.3 | -4.7 | -4.7 | -7.7 | -10.1 |
| EBITA margin | -89.0% | -49.8% | -36.2% | -23.0% | -14.6% | -14.6% | -28.5% | -56.3% |
| Amortization of intangibles | | | | | 0.1 | 0.1 | 0.2 | 0.3 |
| EBIT | -40.5 | -24.1 | -15.2 | -9.3 | -4.9 | -4.9 | -7.8 | -10.4 |
| EBIT margin | -89.0% | -49.8% | -36.2% | -23.0% | -15.0% | -15.0% | -29.2% | -57.9% |
| Pre-tax income | -47.4 | -26.9 | -16.7 | -12.0 | -7.9 | -8.0 | -26.2 | -18.9 |
| Income taxes | 0.3 | -0.2 | 0.1 | 0.0 | 0.1 | 0.1 | -0.5 | 0.3 |
| Tax rate | | 0.7% | | 0.2% | | | 2.1% | |
| Net income | -47.7 | -26.7 | -16.8 | -30.3 | -18.5 | -18.5 | -32.8 | -21.3 |
| Net margin | -104.6% | -55.2% | -39.9% | -75.0% | -57.0% | -57.0% | -122.3% | -118.7% |
| |
| Diluted EPS | ($2.79) | ($1.67) | ($1.33) | ($8.46) | ($293.34) | ($293.34) | ($520.18) | ($1.85) |
| Shares outstanding (diluted) | 17.1 | 16.0 | 12.6 | 3.6 | 0.1 | 0.1 | 0.1 | 11.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|